methotrexate has been researched along with Myasthenia Gravis in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (24.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (12.00) | 29.6817 |
| 2010's | 11 (44.00) | 24.3611 |
| 2020's | 5 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonanno, C; Brizzi, T; Lupica, A; Musumeci, O; Nicocia, G; Pugliese, A; Rodolico, C; Toscano, A; Trimarchi, G | 1 |
| Bertelle, D; Bixio, R; Carletto, A; Pedrollo, E; Pistillo, F; Rossini, M; Viapiana, O | 1 |
| Da, Y; Di, L; Lu, Y; Shen, F; Wang, M; Wen, X; Zhu, W | 1 |
| Adiao, KJB; Prado, MB | 1 |
| Benatar, M; Cea, G; Evoli, A; Gilhus, NE; Illa, I; Kuntz, NL; Massey, J; Melms, A; Murai, H; Narayanaswami, P; Nicolle, M; Palace, J; Richman, D; Sanders, DB; Verschuuren, J; Wolfe, G | 1 |
| Europa, TA; Heckmann, JM; Nel, M | 1 |
| Abrahams, A; Auret, J; Heckmann, JM; Prince, S | 1 |
| Bahceci, HK; Bal, A; Cakcı, A; Dulgeroglu, D; Karaahmet, OZ | 1 |
| Barohn, RJ; Becker, M; Benatar, M; Bril, V; Burns, TM; David, W; Dimachkie, MM; Elsheikh, BH; Goyal, N; He, J; Herbelin, L; Howard, JF; Jackson, C; Kissel, JT; Mozaffar, T; Nations, S; Pasnoor, M; Pazcuzzi, R; Pulley, M; Rosenfeld, J; Saperstein, D; Shaibani, JA; Simpson, E; Statland, JM; Swenson, A; Wang, AK; Wicklund, M | 1 |
| Bateman, K; Heckmann, JM | 1 |
| Kelkar, P | 1 |
| Pasnoor, M | 1 |
| Ebert, S; Nau, R; Schweiger, KP | 1 |
| Badri, M; Bateman, K; Heckmann, JM; Rawoot, A; Renison, R | 1 |
| Bereznai, B; Boczán, J; Lovas, G; Molnár, MJ; Pál, Z | 1 |
| Barohn, RJ; Dimachkie, M; He, J; Herbelin, L; Pasnoor, M | 1 |
| Finelli, PF | 1 |
| Boyle, R; Cheung, C; Dua, U; Gandhi, MK; Gill, D; Nourse, J; Tran, H | 1 |
| Heller, I; Isakov, A; Kornizky, Y; Shapira, I; Topilsky, M | 1 |
| Balzereit, F; Leipert, M; Mertens, HG | 1 |
| Aarli, JA | 1 |
| Cendrowski, W; Riekkinen, PJ; Rinne, UK | 1 |
| Ceci, A; Mitolo-chieppa, D | 1 |
| Rowland, LP | 1 |
| Dietel, K; Rüster, M | 1 |
5 review(s) available for methotrexate and Myasthenia Gravis
| Article | Year |
|---|---|
Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options.
Topics: Adalimumab; Arthritis, Rheumatoid; Female; Humans; Janus Kinase Inhibitors; Male; Methotrexate; Middle Aged; Myasthenia Gravis | 2022 |
Methotrexate in generalized myasthenia gravis: a systematic review.
Topics: Azathioprine; Drug-Related Side Effects and Adverse Reactions; Humans; Immunosuppressive Agents; Methotrexate; Myasthenia Gravis; Observational Studies as Topic; Prednisone; Randomized Controlled Trials as Topic | 2023 |
International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update.
Topics: Antibodies, Monoclonal, Humanized; Consensus; Disease Management; Humans; Immune Checkpoint Inhibitors; Immunosuppressive Agents; Methotrexate; Myasthenia Gravis; Rituximab; Thymectomy | 2021 |
[Immunosuppressive treatment in neurological disorders].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Animals; Antilymphocyte Serum; Azathioprine; Cyclophosphamide; Encephalomyelitis, Autoimmune, Experimental; Humans; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Multiple Sclerosis; Myasthenia Gravis; Polyradiculopathy; Thymectomy | 1973 |
Immunosuppressive therapy in neurological diseases.
Topics: Adrenocorticotropic Hormone; Azathioprine; Central Nervous System Diseases; Cyclophosphamide; Cytarabine; Encephalitis; Female; Humans; Hydrocortisone; Immunity, Cellular; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocyte Activation; Methotrexate; Multiple Sclerosis; Myasthenia Gravis; Myositis; Neuritis; Polyradiculopathy; Prednisone; Virus Diseases | 1974 |
4 trial(s) available for methotrexate and Myasthenia Gravis
| Article | Year |
|---|---|
A Randomized Open-Labeled Trial of Methotrexate as a Steroid-Sparing Agent for Patients With Generalized Myasthenia Gravis.
Topics: Area Under Curve; Humans; Methotrexate; Myasthenia Gravis; Prednisone; Prospective Studies | 2022 |
A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Autoantibodies; Canada; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myasthenia Gravis; Prednisone; Receptors, Cholinergic; Severity of Illness Index; Treatment Outcome; United States | 2016 |
A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis.
Topics: Adult; Azathioprine; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myasthenia Gravis; Prednisone; Single-Blind Method | 2011 |
Phase II trial of methotrexate in myasthenia gravis.
Topics: Double-Blind Method; Humans; Immunosuppressive Agents; Methotrexate; Myasthenia Gravis; Placebos; Quality of Life | 2012 |
16 other study(ies) available for methotrexate and Myasthenia Gravis
| Article | Year |
|---|---|
Methotrexate as a Steroid-Sparing Agent in Myasthenia Gravis: A Preliminary Retrospective Study.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Methotrexate; Myasthenia Gravis; Prednisone; Retrospective Studies | 2021 |
Myasthenic ophthalmoparesis: Time To resolution after initiating immune therapies.
Topics: Adult; Azathioprine; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myasthenia Gravis; Ophthalmoplegia; Plasma Exchange; Prednisone; Proportional Hazards Models; Recovery of Function; Time Factors; Treatment Outcome; Young Adult | 2018 |
The effects of prednisone and steroid-sparing agents on decay accelerating factor (CD55) expression: implications in myasthenia gravis.
Topics: Animals; Azathioprine; CD55 Antigens; Cell Line; Chlorocebus aethiops; COS Cells; Cyclosporine; Glucocorticoids; Humans; Methotrexate; Mice; Myasthenia Gravis; Prednisone | 2014 |
Methotrexate treatment in myasthenia gravis.
Topics: Adult; Arthritis, Rheumatoid; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Myasthenia Gravis | 2014 |
Letter re: A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.
Topics: Humans; Methotrexate; Myasthenia Gravis; Prednisone | 2017 |
Letter re: A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.
Topics: Humans; Methotrexate; Myasthenia Gravis; Prednisone | 2017 |
Author response: A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis.
Topics: Humans; Methotrexate; Myasthenia Gravis; Plasma Exchange | 2017 |
Candida esophagitis as the cause of swallowing disturbances in an 85-year-old patient with myasthenia gravis.
Topics: Aged; Antifungal Agents; Candidiasis; Deglutition Disorders; Diagnosis, Differential; Drug Therapy, Combination; Esophagitis; Gastroscopy; Humans; Immunosuppressive Agents; Male; Methotrexate; Myasthenia Gravis; Nystatin; Prednisolone; Pyridostigmine Bromide | 2011 |
[Therapy for anti-MuSK antibody positive myasthenia gravis].
Topics: Adult; Autoantibodies; Azathioprine; Female; Humans; Immunosuppressive Agents; Methotrexate; Myasthenia Gravis; Plasma Exchange; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Treatment Failure; Treatment Outcome | 2011 |
Primary CNS lymphoma in myasthenic on long-term azathioprine.
Topics: Antigens, CD20; Antimetabolites, Antineoplastic; Azathioprine; Brain Neoplasms; Diagnosis, Differential; Female; Humans; Immunohistochemistry; Immunosuppressive Agents; Lymphoma; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Myasthenia Gravis | 2005 |
Methotrexate-associated mantle-cell lymphoma in an elderly man with myasthenia gravis.
Topics: Aged; Diagnosis, Differential; Humans; Immunosuppressive Agents; Lymphocytes; Lymphocytosis; Lymphoma, Mantle-Cell; Male; Methotrexate; Myasthenia Gravis; Risk Factors | 2008 |
Dysphagia with multiple autoimmune disease.
Topics: Aged; Anti-Inflammatory Agents; Biopsy; Deglutition Disorders; Diagnosis, Differential; Esophageal Achalasia; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Methotrexate; Muscles; Myasthenia Gravis; Polymyositis; Prednisone; Time Factors | 2000 |
The treatment of severe myasthenia gravis with immunosuppressive agents.
Topics: Adolescent; Adult; Age Factors; Agranulocytosis; Aminopterin; Azathioprine; Chemical and Drug Induced Liver Injury; Cholinesterase Inhibitors; Dactinomycin; Drug Synergism; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Methotrexate; Middle Aged; Myasthenia Gravis; Time Factors | 1969 |
[Neurotoxicity of some antineoplastic agents].
Topics: Antineoplastic Agents; Child; Child, Preschool; Doxorubicin; Facial Paralysis; Humans; Infant; Leukemia; Lymphoma; Methotrexate; Motor Neurons; Myasthenia Gravis; Neoplasms; Nervous System; Nervous System Diseases; Paresthesia; Seizures; Vinblastine; Vincristine | 1974 |
Immunosuppressive drugs in treatment of myasthenia gravis.
Topics: Adult; Autoimmune Diseases; Azathioprine; Blood Cell Count; Busulfan; Cyclophosphamide; Female; Humans; Hypersensitivity, Delayed; Immunosuppressive Agents; Male; Melphalan; Mercaptopurine; Methotrexate; Myasthenia Gravis | 1971 |
[Therapy of myasthenia gravis pseudoparalytica].
Topics: Antineoplastic Agents; Child; Female; Humans; Infant; Methotrexate; Myasthenia Gravis; Paralysis; Prednisone; Pyridostigmine Bromide | 1970 |